Azimuth Pharma Limited - Accounts to registrar (filleted) - small 18.2
Azimuth Pharma Limited - Accounts to registrar (filleted) - small 18.2
| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 March 2019 |
| for |
| AZIMUTH PHARMA LIMITED |
| AZIMUTH PHARMA LIMITED (REGISTERED NUMBER: 07916512) |
| Contents of the Financial Statements |
| for the Year Ended 31 March 2019 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 4 |
| AZIMUTH PHARMA LIMITED |
| Company Information |
| for the Year Ended 31 March 2019 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| 26 Eastwick Drive |
| Great Bookham |
| Leatherhead |
| Surrey |
| KT23 3PR |
| AZIMUTH PHARMA LIMITED (REGISTERED NUMBER: 07916512) |
| Balance Sheet |
| 31 March 2019 |
| 2019 | 2018 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Investments | 3 |
| CURRENT ASSETS |
| Debtors | 4 |
| Cash at bank |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
5 |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital |
| Retained earnings |
| SHAREHOLDERS' FUNDS |
| The directors acknowledge their responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| AZIMUTH PHARMA LIMITED (REGISTERED NUMBER: 07916512) |
| Balance Sheet - continued |
| 31 March 2019 |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements were approved by the Board of Directors on |
| S Bennett - Director | G Smith - Director |
| M Stanton - Director |
| AZIMUTH PHARMA LIMITED (REGISTERED NUMBER: 07916512) |
| Notes to the Financial Statements |
| for the Year Ended 31 March 2019 |
| 1. | STATUTORY INFORMATION |
| Azimuth Pharma Limited is a |
| company's registered number and registered office address can be found on the Company Information page. |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Investments in subsidiaries |
| Investments in subsidiary undertakings are recognised at cost. |
| 3. | FIXED ASSET INVESTMENTS |
| Shares in |
| group |
| undertakings |
| £ |
| COST |
| At 1 April 2018 |
| and 31 March 2019 |
| NET BOOK VALUE |
| At 31 March 2019 |
| At 31 March 2018 |
| The company's investments at the Balance Sheet date in the share capital of companies include the following: |
| Registered office: 22 Great James Street, London, WC1N 3ES |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2019 | 2018 |
| £ | £ |
| Aggregate capital and reserves |
| Profit for the year |
| Registered office: 22 Great James Street, London, WC1N 3ES |
| Nature of business: |
| % |
| Class of shares: | holding |
| 2019 | 2018 |
| £ | £ |
| Aggregate capital and reserves |
| AZIMUTH PHARMA LIMITED (REGISTERED NUMBER: 07916512) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 March 2019 |
| 3. | FIXED ASSET INVESTMENTS - continued |
| Registered office: 22 Great James Street, London, WC1N 3ES |
| Nature of business: |
| % |
| Class of shares: | holding |
| £ | £ |
| Aggregate capital and reserves |
| 4. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2019 | 2018 |
| £ | £ |
| Amounts owed by group undertakings |
| 5. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2019 | 2018 |
| £ | £ |
| Amounts owed to group undertakings |